Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
Portfolio Pulse from Benzinga Insights
Twist Bioscience (NASDAQ:TWST) has received mixed analyst ratings over the past three months, with a recent positive shift in average price targets. Analysts have set a 12-month average price target of $49.4, up 9.78% from the previous $45.00. The company's financials show a positive revenue trend but face challenges with net margin, ROE, and ROA.
October 01, 2024 | 6:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience has received mixed analyst ratings, with a recent positive shift in average price targets to $49.4. The company's financials show a positive revenue trend but face challenges with net margin, ROE, and ROA.
The positive shift in average price targets suggests a bullish sentiment among analysts, which could lead to a short-term increase in TWST's stock price. However, the company's financial challenges in net margin, ROE, and ROA may temper long-term expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100